ZA202100106B - Methods of treating and/or preventing actinic keratosis - Google Patents

Methods of treating and/or preventing actinic keratosis

Info

Publication number
ZA202100106B
ZA202100106B ZA2021/00106A ZA202100106A ZA202100106B ZA 202100106 B ZA202100106 B ZA 202100106B ZA 2021/00106 A ZA2021/00106 A ZA 2021/00106A ZA 202100106 A ZA202100106 A ZA 202100106A ZA 202100106 B ZA202100106 B ZA 202100106B
Authority
ZA
South Africa
Prior art keywords
treating
methods
actinic keratosis
preventing actinic
preventing
Prior art date
Application number
ZA2021/00106A
Other languages
English (en)
Inventor
Min-Fun Rudolf Kwan
Johnson Yiu-Nam Lau
E Douglas Kramer
David Lawrence Cutler
Jane Fang
Original Assignee
Athenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63446658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA202100106(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Athenex Inc filed Critical Athenex Inc
Publication of ZA202100106B publication Critical patent/ZA202100106B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2021/00106A 2017-03-10 2021-01-07 Methods of treating and/or preventing actinic keratosis ZA202100106B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762469889P 2017-03-10 2017-03-10

Publications (1)

Publication Number Publication Date
ZA202100106B true ZA202100106B (en) 2022-08-31

Family

ID=63446658

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/00106A ZA202100106B (en) 2017-03-10 2021-01-07 Methods of treating and/or preventing actinic keratosis

Country Status (13)

Country Link
US (3) US10617693B2 (enExample)
EP (2) EP3592355B1 (enExample)
JP (3) JP7502863B2 (enExample)
KR (2) KR20190141661A (enExample)
CN (1) CN110891575A (enExample)
AU (2) AU2018231144B2 (enExample)
BR (1) BR112019018687A2 (enExample)
CA (1) CA3055938A1 (enExample)
IL (1) IL269182B2 (enExample)
MX (2) MX387658B (enExample)
TW (1) TWI841523B (enExample)
WO (1) WO2018165647A1 (enExample)
ZA (1) ZA202100106B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968574B2 (en) * 2004-12-28 2011-06-28 Kinex Pharmaceuticals, Llc Biaryl compositions and methods for modulating a kinase cascade
BR112019018687A2 (pt) * 2017-03-10 2020-04-07 Athenex, Inc. métodos de tratamento e/ou prevenção da ceratose actínica
FI3679016T3 (fi) 2017-09-07 2025-12-12 Atnx Spv Llc 2-(5-(4-(2-morfolinoetoksi)fenyyli)pyridin-2-yyli)-n-bentsyyliasetamidin kiinteitä muotoja
CA3092939C (en) * 2018-03-07 2024-10-08 Atnx Spv, Llc USE OF THE COMBINATION OF KX01 AND VITAMIN D TO TREAT HYPERPROLIFERATIVE SKIN DISORDERS
WO2019188918A1 (ja) * 2018-03-28 2019-10-03 テルモ株式会社 医療デバイスおよび処置用法
WO2020247706A1 (en) * 2019-06-05 2020-12-10 Athenex, Inc. Methods of treating and/or preventing psoriasis
EP4263833A1 (en) * 2021-01-21 2023-10-25 Sirnaomics, Inc. Compositions and methods for treatment of skin cancers
CN120152984A (zh) * 2023-10-13 2025-06-13 恩康药业科技（广州）有限公司 治疗和/或预防日光性角化病的化合物及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968574B2 (en) 2004-12-28 2011-06-28 Kinex Pharmaceuticals, Llc Biaryl compositions and methods for modulating a kinase cascade
DK1836169T5 (da) 2004-12-28 2023-10-09 Atnx Spv Llc Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser
EP2041071B1 (en) 2006-06-29 2014-06-18 Kinex Pharmaceuticals, LLC Biaryl compositions and methods for modulating a kinase cascade
WO2008030892A2 (en) * 2006-09-05 2008-03-13 Bipar Sciences, Inc. Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
US7939529B2 (en) 2007-05-17 2011-05-10 Kinex Pharmaceuticals, Llc Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
TWI457336B (zh) 2006-12-28 2014-10-21 Kinex Pharmaceuticals Llc 調節激酶級聯之組成物及方法
US7935697B2 (en) 2006-12-28 2011-05-03 Kinex Pharmaceuticals, Llc Compositions for modulating a kinase cascade and methods of use thereof
WO2008144045A1 (en) 2007-05-17 2008-11-27 Kinex Pharmaceuticals, Llc Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
EP2143421A1 (en) 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
RS58566B1 (sr) * 2008-12-19 2019-05-31 Medicis Pharmaceutical Corp Formulacije imikuimoda niže dozne jačine i kratkih režima doziranja za lečenje aktinične keratoze
US8741857B1 (en) * 2012-01-30 2014-06-03 Lawrence Moy Treatments for actinic keratoses
NZ606177A (en) * 2012-01-30 2014-03-28 Dolorgiet Gmbh & Co Kg Compositions for the treatment of actinic keratosis
EP2872161B1 (en) 2012-06-26 2020-12-16 Del Mar Pharmaceuticals Dianhydrogalactitol for use in treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations
BR112019018687A2 (pt) * 2017-03-10 2020-04-07 Athenex, Inc. métodos de tratamento e/ou prevenção da ceratose actínica

Also Published As

Publication number Publication date
KR20240090837A (ko) 2024-06-21
TWI841523B (zh) 2024-05-11
IL269182A (en) 2019-11-28
US10617693B2 (en) 2020-04-14
MX2019010707A (es) 2020-01-15
RU2019131757A3 (enExample) 2021-05-31
US11497750B2 (en) 2022-11-15
AU2024201828A1 (en) 2024-05-02
MX387658B (es) 2025-03-18
IL269182B1 (en) 2023-07-01
TW201842913A (zh) 2018-12-16
IL269182B2 (en) 2023-11-01
EP4659740A2 (en) 2025-12-10
KR20190141661A (ko) 2019-12-24
CN110891575A (zh) 2020-03-17
EP3592355B1 (en) 2025-12-10
WO2018165647A1 (en) 2018-09-13
AU2018231144B2 (en) 2023-12-21
JP2023015269A (ja) 2023-01-31
BR112019018687A2 (pt) 2020-04-07
AU2018231144A1 (en) 2019-10-03
EP3592355A1 (en) 2020-01-15
US20230172942A1 (en) 2023-06-08
US20180256589A1 (en) 2018-09-13
CA3055938A1 (en) 2018-09-13
RU2019131757A (ru) 2021-04-12
JP2025029010A (ja) 2025-03-05
MX2021013354A (es) 2021-11-18
US20200197405A1 (en) 2020-06-25
JP7502863B2 (ja) 2024-06-19
EP3592355A4 (en) 2021-01-06
JP2020510042A (ja) 2020-04-02

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
ZA202100106B (en) Methods of treating and/or preventing actinic keratosis
SG10202101986UA (en) Tetracycline compounds and methods of treatment
ZA201905677B (en) Glycan-interacting compounds and methods of use
HUE050455T2 (hu) Rendszerek és eljárások több részletességi szint renderelésére
IL256025A (en) Methods of diagnosing and treating cancer
HUE068842T2 (hu) Vegyületek és alkalmazási eljárásaik
IL261343A (en) Transposon system and methods of use
GB201609786D0 (en) Compounds and method of use
EP3684342C0 (en) TREATMENT PROCEDURES
GB201706406D0 (en) Method of treatment
GB201815588D0 (en) Method of treatment
LT3661510T (lt) Elgesio pakitimų gydymo būdai
GB201615023D0 (en) Method and system for treatment of produced water
GB201616009D0 (en) Treatment and/or prevention of sepsis
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201817198D0 (en) Treatment ported sub and method of use
GB201621737D0 (en) Compositions and methods of treatment
EP3659407C0 (en) METHOD AND PLANT FOR TREATMENT OF PLATES
GB201605127D0 (en) Composition and methods of treatment
ZA201906439B (en) Water treatment system and method of use thereof
IL271727A (en) Method of treatment and their dosage forms
HK40020549A (en) Methods of treating and/or preventing actinic keratosis
GB201710491D0 (en) Composition and methods of treatment
GB201617715D0 (en) Methods for the treatment and prevention of ebola